Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Safety of TimoD Sustained-Release Implant in Participants With Glaucoma or Ocular Hypertension Undergoing Cataract Surgery
Phase 1
Recruiting
- Conditions
- GlaucomaOcular Hypertension
- Interventions
- Drug: TimoD implantDevice: Injector system
- First Posted Date
- 2025-06-25
- Last Posted Date
- 2025-06-25
- Lead Sponsor
- EyeD Pharma
- Target Recruit Count
- 18
- Registration Number
- NCT07036510
- Locations
- 🇵🇦
Panama Eye Center, Panama City, Panama
Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma
Phase 1
Terminated
- Conditions
- Primary Open-angle Glaucoma
- Interventions
- Drug: TimoD implantDevice: Injector system
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2025-07-16
- Lead Sponsor
- EyeD Pharma
- Target Recruit Count
- 1
- Registration Number
- NCT06321562
- Locations
- 🇩🇪
Breyer, Kaymak & Klabe Augenchirurgie, Düsseldorf, Germany
🇩🇪Universitäts-Augenklinik Heidelberg, Heidelberg, Germany
🇩🇪Universitätsaugenklinik Magdeburg, Magdeburg, Germany
News
No news found